ANACOR PHARMACEUTICALS INC's ticker is ANAC and the CUSIP is 032420101. A total of 215 filers reported holding ANACOR PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 0.58 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $5,027,000 | -86.2% | 94,058 | -69.7% | 0.01% | -88.5% |
| Q3 2015 | $36,544,000 | +1265.6% | 310,458 | +183.9% | 0.09% | +1142.9% |
| Q3 2014 | $2,676,000 | -27.3% | 109,358 | -47.3% | 0.01% | -22.2% |
| Q2 2014 | $3,680,000 | +462.7% | 207,578 | +534.8% | 0.01% | +350.0% |
| Q1 2014 | $654,000 | -63.2% | 32,700 | -69.1% | 0.00% | -50.0% |
| Q4 2013 | $1,775,000 | – | 105,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 1,067,892 | $120,640,000 | 41.48% |
| Palo Alto Investors LP | 2,187,242 | $247,093,000 | 13.75% |
| VHCP Management, LLC | 140,756 | $15,901,000 | 9.61% |
| HWG Holdings LP | 48,910 | $5,525,000 | 5.62% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 906,287 | $102,383,000 | 4.98% |
| Baker Brothers Advisors | 4,198,520 | $474,307,000 | 3.93% |
| Asymmetry Capital Management, L.P. | 15,591 | $1,761,000 | 2.66% |
| NEXT CENTURY GROWTH INVESTORS LLC | 496,744 | $56,117,000 | 2.42% |
| AlpInvest Partners B.V. | 11,551 | $1,305,000 | 2.17% |
| Atika Capital Management LLC | 36,000 | $4,067,000 | 2.09% |